M. Pipkin
Papers
1
Total Citations
24
H-Index
1
About
Dr. M. Pipkin is a leading thoracic surgeon and clinical trialist whose work is shaping the future of minimally invasive lung cancer surgery. Their primary research focuses on the comparative effectiveness of robotic-assisted thoracoscopic surgery (RATS) versus video-assisted thoracoscopic surgery (VATS) for early-stage lung cancer. Dr. Pipkin’s most notable contribution is their leadership of the landmark RAVAL trial, an international, multi-centered, blinded, randomized controlled trial that directly compares these two advanced surgical techniques. This pivotal study, published in 2022 and already garnering 24 citations, aims to provide definitive evidence on whether robotic assistance offers superior outcomes in postoperative pain, mortality, length of stay, and pulmonary complications. By designing a rigorous, blinded protocol, Dr. Pipkin is addressing critical gaps in retrospective data and setting a new standard for evidence-based surgical oncology. Their work is instrumental in helping surgeons and patients make informed decisions about the best approach for lobectomy, ultimately driving innovation and improving recovery for those battling early-stage lung cancer.
Research Focus
Key Achievements
Top Papers
- 1